Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
167.00
0.00 (0.00%)
At close: Sep 9, 2024

Sichuan Kelun-Biotech Biopharmaceutical Revenue

Sichuan Kelun-Biotech Biopharmaceutical had revenue of 1.38B CNY in the half year ending June 30, 2024, with 300.82% growth. This brings the company's revenue in the last twelve months to 1.88B, up 24.71% year-over-year. In the year 2023, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 1.54B with 91.62% growth.

Revenue (ttm)
1.88B CNY
Revenue Growth
+24.71%
P/S Ratio
18.01
Revenue / Employee
1.27M CNY
Employees
1,477
Market Cap
37.21B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.54B736.56M91.62%
Dec 31, 2022803.93M771.61M2,387.26%
Dec 31, 202132.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition